Andere Kunden interessierten sich auch für
![The Promise and Perils of Infrastructure Privatization]( "The Promise and Perils of Infrastructure Privatization")
The Promise and Perils of Infrastructure Privatization37,99 €![The Promise and Perils of Infrastructure Privatization]( "The Promise and Perils of Infrastructure Privatization")
The Promise and Perils of Infrastructure Privatization37,99 €![The Conflict Economics: Valuing the Arm Conflict in Nepal]( "The Conflict Economics: Valuing the Arm Conflict in Nepal")
The Conflict Economics: Valuing the Arm Conflict in Nepal36,99 €![The Real Options Approach]( "The Real Options Approach")
The Real Options Approach38,99 €![The Economic Valuation Of Wildlife Resources Conservation]( "The Economic Valuation Of Wildlife Resources Conservation")
The Economic Valuation Of Wildlife Resources Conservation32,99 €![Valuation Effects on the Business Cycle in Emerging Markets]( "Valuation Effects on the Business Cycle in Emerging Markets")
Valuation Effects on the Business Cycle in Emerging Markets44,99 €![The Choice of Tax Shields¿ Discount Rate on Firm Valuation]( "The Choice of Tax Shields¿ Discount Rate on Firm Valuation")
The Choice of Tax Shields¿ Discount Rate on Firm Valuation36,99 €
This monograph attempts to present an in-depth analysis about the obstacles involved with the implementation of Real Options valuation technique, for making investment decisions under uncertain business environment. The model traces back its origin from the famed Black&Scholes (1973) model for option valuation, for financial assets. However recently a lot of academicians have made several attempts to use the same model, for valuing options which are inherently embedded within projects that firms undertake, thereby allowing firms (managers) to make informed investment decisions, by capturing the value of new information and managerial flexibility, during the various stages of the project. However it needs to be examined carefully, that the Black&Scholes model for option volatility, is based on certain assumptions, which if violated cannot correctly price the value of a european call option. This monograph by using a case study method attempts to demonstrate the problems associatedwith the implementation of Real Options valuation technique, for valuing R&D projects in Pharmaceutical industry.